{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-004178","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2024-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.714025+00:00","generated_at":"2026-06-04T03:39:45.691004+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Catheter Precision reports FY2023 revenue $442K; net loss ($70.6M) includes $60.9M goodwill impairment","bullets":["Full-year 2023 revenue $442K vs $14K in 2022; Q4 revenue $128.8K vs zero in prior-year quarter.","Net loss of ($70.6M) includes $60.9M one-time goodwill impairment; operating expenses $78.5M.","Cash on hand $3.6M as of Dec 31, 2023; cash decreased $12.3M during the year.","Clinical progress: VIVO European Registry enrolled 125 patients; LockeT initial trial >100 patients, second trial expected mid-2024.","Intellectual property: 8 patent applications filed and 6 patents issued in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-004178","json":"https://secwatch.observer/filing/0001654954-24-004178.json","markdown":"https://secwatch.observer/filing/0001654954-24-004178.md","text":"https://secwatch.observer/filing/0001654954-24-004178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/0001654954-24-004178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/rmed_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:39:45.691004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f940e94256f3f13a952ed148b6d540cb0bb459d7","claim":"Catheter Precision, Inc. reported the quarter and year ended December 31, 2023 results: revenue $442 thousand, net income ($70.6) million.","evidence_excerpt":"Total revenues for the year ended December 31, 2023 were $442 thousand.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/0001654954-24-004178-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Revenue","value":"$442 thousand"},{"label":"Net income","value":"($70.6) million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}